Skip to main content
. 2021 Dec 24;37(2):300–310. doi: 10.46497/ArchRheumatol.2022.9049

Table 3. Outcome of the patients with vasculitis induced by a biological molecule in whom the drug was maintained or rechallenged with the same or other biological agent.

  n
Total of patients who had the drug suspended and later rechallenged with an alternative biologic agent  
No. of patients 23
Recurrence of the vasculitis 4
No recurrence of the vasculitis 19
Total of patients who had the drug suspended and later rechallenged with the same biologic agent  
No. of patients 10
Recurrence of the vasculitis 7
No recurrence of the vasculitis 3
Outcome of patients who had the medication maintained  
No. of patients 6
Worsened of the vasculitis 1
Improved of the vasculitis 5